These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 16723360)
41. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Recchia FM; Ruby AJ; Carvalho Recchia CA Am J Ophthalmol; 2005 Mar; 139(3):447-54. PubMed ID: 15767052 [TBL] [Abstract][Full Text] [Related]
42. Long-term results of pars plana vitrectomy in the management of complicated uveitis. Heiligenhaus A; Bornfeld N; Foerster MH; Wessing A Br J Ophthalmol; 1994 Jul; 78(7):549-54. PubMed ID: 7918267 [TBL] [Abstract][Full Text] [Related]
43. intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group. Wu L; Hernandez-Bogantes E; Roca JA; Arevalo JF; Barraza K; Lasave AF Retina; 2011 Feb; 31(2):298-303. PubMed ID: 21099452 [TBL] [Abstract][Full Text] [Related]
44. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Yanyali A; Nohutcu AF; Horozoglu F; Celik E Am J Ophthalmol; 2005 May; 139(5):795-801. PubMed ID: 15860282 [TBL] [Abstract][Full Text] [Related]
45. Intravitreal triamcinolone acetonide versus pars plana vitrectomy for pseudophakic cystoid macular edema. Sevim MS; Sanisoglu H; Turkyilmaz K Curr Eye Res; 2012 Dec; 37(12):1165-70. PubMed ID: 22928501 [TBL] [Abstract][Full Text] [Related]
46. Pars plana vitrectomy for chronic pseudophakic cystoid macular edema. Harbour JW; Smiddy WE; Rubsamen PE; Murray TG; Davis JL; Flynn HW Am J Ophthalmol; 1995 Sep; 120(3):302-7. PubMed ID: 7661201 [TBL] [Abstract][Full Text] [Related]
47. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology. Sørensen TL; Haamann P; Villumsen J; Larsen M Acta Ophthalmol Scand; 2005 Feb; 83(1):67-70. PubMed ID: 15715560 [TBL] [Abstract][Full Text] [Related]
48. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema. Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632 [TBL] [Abstract][Full Text] [Related]
49. Long-term results of pars plana vitrectomy as an anti-inflammatory therapy of pediatric intermediate uveitis resistant to standard medical treatment. Darsová D; Pochop P; Štěpánková J; Dotřelová D Eur J Ophthalmol; 2018 Jan; 28(1):98-102. PubMed ID: 28862736 [TBL] [Abstract][Full Text] [Related]
50. Vitrectomy for diabetic macular edema with and without internal limiting membrane removal. Yamamoto T; Hitani K; Sato Y; Yamashita H; Takeuchi S Ophthalmologica; 2005; 219(4):206-13. PubMed ID: 16088239 [TBL] [Abstract][Full Text] [Related]
51. Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies. Soheilian M; Karimi S; Ramezani A; Peyman GA Retina; 2010 Mar; 30(3):509-15. PubMed ID: 19952986 [TBL] [Abstract][Full Text] [Related]
52. Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Ikeda T; Sato K; Katano T; Hayashi Y Br J Ophthalmol; 1999 Jan; 83(1):12-4. PubMed ID: 10209427 [TBL] [Abstract][Full Text] [Related]
53. Pars plana vitrectomy for aphakic cystoid macular edema. Patel A; de Bustros S; Michels RG Retina; 1985; 5(1):11-5. PubMed ID: 4001583 [TBL] [Abstract][Full Text] [Related]